Repository: UIHistories Project: Board of Trustees Minutes - 1982 [PAGE 485]

EXTRACTED TEXT FROM PAGE:

474

BOARD OF T R U S T E E S

[ F e b r u a r y 18

to the University of Illinois Foundation. U P I is the licensing agent of the University of Illinois Foundation. In connection with this option and license agreement, Baxter wishes to support further research at the Chicago Circle campus relative to the development and testing of artificial cells for oxygen transport. T h e support would be $50,000 a year until terminated by either Baxter or the University. 1 Under the proposed contract the University would agree that any patentable inventions and nonpatentable technology resulting from the supported research would be exclusively licensed to Baxter. Prior to any publication of the results of the research, the University would further agree to give Baxter a period of six months to comment and advise on the patentability aspects. T h e University Patent Committee has reviewed the proposed exceptions to The General Rules Concerning University Organization and Procedure and has recommended approval. The executive vice president concurs. I recommend approval.

On motion of Mr. Forsyth, this recommendation was approved.

Recommendations of the University Patent Committee (12) T h e University Patent Committee has recommended that the following actions be taken with regard to inventions and discoveries made at the University of Illinois. Background information concerning the individual items has been sent to the Committee on Patents of the Board of Trustees. 1. Method to Assay Cell Sensitivity to Thymidine — Harvard Reiter, professor of microbiology in the Department of Microbiology and Immunology, Medical Center, inventor. University Patents, Inc., reported that there was little commercial interest and that it did not wish to commercialize this method. The inventor has stated that the marketability of this method, if any, will be in five or ten years. He would like to pursue a patent at his own expense. The University Patent Committee recommends that the University retain rights to use the method and release all other patent rights to the inventor. 2. New Chlorophyll a and b Isolated from a Mutant of Zea mays L — Maarib B. Bazzaz, visiting assistant professor of botany, Urbana-Champaign, inventor; developed with support from the National Science Foundation. University Patents, Inc., released its right of first refusal in this discovery because of inadequate time to determine patentability and commercial potential. Two articles describing the invention were published in February 1981. There is a further question as to the patentability of the discovery because the isolated chlorophyll compounds are found in nature. T h e University Patent Committee recommends that the University retain rights to make and use the invention and release all other patent rights to the inventor, subject to the rights of the sponsor, the Naional Science Foundation. I concur.

On motion of Mr. Forsyth, these recommendations were approved.

Agreement w i t h Sulcon, inc., W i l l a r d Airport, U r b a n a (13) Negotiations have been completed with Sulcon, Inc., of Urbana, Illinois, fprv the use of Building Number 658 at the University of Illinois-Willard Airport. T h e

1 Baxter Travenol Laboratories is also supporting a tandem research project to be conducted ' on the same subject at Rush-Presbyterian-St. Luke s Hospital by a^ former University employee who was a coinventor on the original patent owned by the Foundation. It is anticipated that an'" agreement will be negotiated between the University and the recipient of the tandem grant with respect to any cooperative work on the two Baxter Travenol Laboratories grants.